Published in J Clin Oncol on March 15, 2002
Clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancer. J Natl Cancer Inst Monogr (2014) 2.13
Randomized trial of a hypnosis intervention for treatment of hot flashes among breast cancer survivors. J Clin Oncol (2008) 1.93
How many repeated measures in repeated measures designs? Statistical issues for comparative trials. BMC Med Res Methodol (2003) 1.62
Hormone replacement therapy: a time for pause. CMAJ (2002) 1.52
Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomized controlled trial. Menopause (2009) 1.45
Botanical and dietary supplements for menopausal symptoms: what works, what does not. J Womens Health (Larchmt) (2005) 1.19
Feeling too hot or cold after breast cancer: is it just a nuisance or a potentially important prognostic factor? Int J Hyperthermia (2010) 0.97
Soy intake in association with menopausal symptoms during the first 6 and 36 months after breast cancer diagnosis. Breast Cancer Res Treat (2010) 0.89
The Study on the Effects of Pimpinella anisum on Relief and Recurrence of Menopausal Hot Flashes. Iran J Pharm Res (2012) 0.89
Soy, red clover, and isoflavones and breast cancer: a systematic review. PLoS One (2013) 0.88
Estrogenic botanical supplements, health-related quality of life, fatigue, and hormone-related symptoms in breast cancer survivors: a HEAL study report. BMC Complement Altern Med (2011) 0.88
Risk factors, pathophysiology, and treatment of hot flashes in cancer. CA Cancer J Clin (2013) 0.84
Efficacy of phytoestrogens for menopausal symptoms: a meta-analysis and systematic review. Climacteric (2014) 0.84
A systematic review of non-hormonal treatments of vasomotor symptoms in climacteric and cancer patients. Springerplus (2015) 0.82
Quantitative efficacy of soy isoflavones on menopausal hot flashes. Br J Clin Pharmacol (2015) 0.80
Herbal Medicine for Hot Flushes Induced by Endocrine Therapy in Women with Breast Cancer: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med (2016) 0.79
Cooling off hot flashes. J Clin Oncol (2002) 0.79
Long-term exposure to dietary sources of genistein induces estrogen-independence in the human breast cancer (MCF-7) xenograft model. Mol Nutr Food Res (2014) 0.79
A practical guide to the management of menopausal symptoms in breast cancer patients. Support Care Cancer (2005) 0.78
The pharmacological and hormonal therapy of hot flushes in breast cancer survivors. Breast Cancer (2015) 0.78
Effects of calci soya balance and vitagnus on menopausal symptoms. Iran Red Crescent Med J (2014) 0.77
Phytoestrogens and antioxidants--bits of experimental evidence. MedGenMed (2005) 0.77
Safety issues of soy phytoestrogens in breast cancer patients. J Clin Oncol (2002) 0.76
Long-term chinese herbs decoction administration for management of hot flashes associated with endocrine therapy in breast cancer patients. Chin J Cancer Res (2011) 0.76
Comparative study of gabapentin and isoflavone in menopausal vasomotor symptoms. J Midlife Health (2016) 0.75
Combining pain therapy with lifestyle: the role of personalized nutrition and nutritional supplements according to the SIMPAR Feed Your Destiny approach. J Pain Res (2016) 0.75
A phase II double-blinded study to evaluate the efficacy of EW02 in reducing chemotherapy-induced neutropenia in breast cancer. Oncol Lett (2015) 0.75
Randomized trial to assess the impact of venlafaxine and soy protein on hot flashes and quality of life in men with prostate cancer. J Clin Oncol (2013) 0.75
How are Interactions Taken into Account in Studies on Conventional and Complementary Therapies for Breast Cancer Patients with Menopausal Complaints? Geburtshilfe Frauenheilkd (2012) 0.75
Exemestane for breast-cancer prevention in postmenopausal women. N Engl J Med (2011) 8.19
Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst (2005) 5.65
Ki67 in breast cancer: prognostic and predictive potential. Lancet Oncol (2010) 5.25
Regional Nodal Irradiation in Early-Stage Breast Cancer. N Engl J Med (2015) 4.94
Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Intern Med (2007) 4.68
Population-based validation of the prognostic model ADJUVANT! for early breast cancer. J Clin Oncol (2005) 4.31
Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial. J Clin Oncol (2008) 4.24
Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival. J Clin Oncol (2006) 3.42
Time to stop progesterone receptor testing in breast cancer management. J Clin Oncol (2004) 3.33
Phase II trial of pertuzumab and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer that progressed during prior trastuzumab therapy. J Clin Oncol (2010) 3.32
Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27--a randomized controlled phase III trial. J Clin Oncol (2013) 3.24
Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med (2004) 3.21
The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancer. Cancer (2007) 2.84
Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study. CMAJ (2009) 2.64
Estrogen receptor status in BRCA1- and BRCA2-related breast cancer: the influence of age, grade, and histological type. Clin Cancer Res (2004) 2.51
Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer. J Clin Oncol (2006) 2.49
Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer. J Clin Oncol (2006) 2.38
Human epidermal growth factor receptor 2 overexpression as a prognostic factor in a large tissue microarray series of node-negative breast cancers. J Clin Oncol (2008) 2.38
Quality of life in MAP.3 (Mammary Prevention 3): a randomized, placebo-controlled trial evaluating exemestane for prevention of breast cancer. J Clin Oncol (2014) 2.25
The relationship between proton pump inhibitor use and longitudinal change in bone mineral density: a population-based study [corrected] from the Canadian Multicentre Osteoporosis Study (CaMos). Am J Gastroenterol (2012) 2.24
Evaluation of indications for and outcomes of elective surgery. CMAJ (2002) 2.21
Consensus conference on breast conservation. J Am Coll Surg (2006) 2.17
Volumetric modulated arc therapy improves dosimetry and reduces treatment time compared to conventional intensity-modulated radiotherapy for locoregional radiotherapy of left-sided breast cancer and internal mammary nodes. Int J Radiat Oncol Biol Phys (2010) 2.08
Randomized phase II study comparing two schedules of everolimus in patients with recurrent/metastatic breast cancer: NCIC Clinical Trials Group IND.163. J Clin Oncol (2009) 2.04
Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of life. J Clin Oncol (2002) 2.04
Hepatitis B knowledge and practices among Chinese immigrants to the United States. Asian Pac J Cancer Prev (2006) 1.91
Overexpression of the anti-adhesin podocalyxin is an independent predictor of breast cancer progression. Cancer Res (2004) 1.90
A randomized controlled trial of interventions to promote cervical cancer screening among Chinese women in North America. J Natl Cancer Inst (2002) 1.83
Identification of cancer care and protocol characteristics associated with recruitment in breast cancer clinical trials. J Clin Oncol (2008) 1.83
Hope and probability: patient perspectives of the meaning of numerical information in cancer communication. Qual Health Res (2006) 1.70
Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy. Int J Radiat Oncol Biol Phys (2009) 1.70
Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents. Breast Cancer Res Treat (2010) 1.65
Ten-year outcomes in a population-based cohort of node-negative, lymphatic, and vascular invasion-negative early breast cancers without adjuvant systemic therapies. J Clin Oncol (2004) 1.61
Impact of routine pathology review on treatment for node-negative breast cancer. J Clin Oncol (2012) 1.59
Validation of a web-based predictive nomogram for ipsilateral breast tumor recurrence after breast conserving therapy. J Clin Oncol (2010) 1.59
Is mastectomy superior to breast-conserving treatment for young women? Int J Radiat Oncol Biol Phys (2007) 1.58
A meta-analysis of the association of fracture risk and body mass index in women. J Bone Miner Res (2014) 1.56
Cancer treatment-induced bone loss in breast and prostate cancer. J Clin Oncol (2008) 1.55
New hope for an oral cancer solution: together we can make a difference. J Can Dent Assoc (2008) 1.55
Primary health care: applying the principles within a community-based participatory health research project that began in a Canadian women's prison. Glob Health Promot (2009) 1.54
Hepatitis B knowledge and practices among Chinese American women in Seattle, Washington. J Cancer Educ (2002) 1.52
Hepatitis B knowledge and practices among Chinese Canadian women in Vancouver, British Columbia. Can J Public Health (2003) 1.50
Age-related variations in the use of axillary dissection: a survival analysis of 8038 women with T1-ST2 breast cancer. Int J Radiat Oncol Biol Phys (2002) 1.50
PPM1H is a p27 phosphatase implicated in trastuzumab resistance. Cancer Discov (2011) 1.50
Is multibeam IMRT better than standard treatment for patients with left-sided breast cancer? Int J Radiat Oncol Biol Phys (2007) 1.49
Correlates of hepatitis B testing among Chinese Americans. J Community Health (2007) 1.48
Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast. Cancer (2005) 1.47
Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy. CMAJ (2004) 1.46
Oral micronized progesterone for vasomotor symptoms--a placebo-controlled randomized trial in healthy postmenopausal women. Menopause (2012) 1.44
Population-based outcomes for small cell lung cancer: impact of standard management policies in British Columbia. Lung Cancer (2004) 1.43
Family history, mammographic density, and risk of breast cancer. Cancer Epidemiol Biomarkers Prev (2010) 1.42
Prognostic associations of 25 hydroxy vitamin D in NCIC CTG MA.21, a phase III adjuvant randomized clinical trial of three chemotherapy regimens in high-risk breast cancer. Breast Cancer Res Treat (2015) 1.42
Does a three-field electron/minitangent photon technique offer dosimetric advantages to a multifield, photon-only technique for accelerated partial breast irradiation? Am J Clin Oncol (2010) 1.39
Pharmacodynamic behavior of liposomal antisense oligonucleotides targeting Her-2/neu and vascular endothelial growth factor in an ascitic MDA435/LCC6 human breast cancer model. Cancer Biol Ther (2004) 1.39
Community-based exercise program reduces risk factors for falls in 65- to 75-year-old women with osteoporosis: randomized controlled trial. CMAJ (2002) 1.38
Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1-related breast carcinoma. Cancer (2003) 1.38
Peak bone mass from longitudinal data: implications for the prevalence, pathophysiology, and diagnosis of osteoporosis. J Bone Miner Res (2010) 1.37
Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy. Int J Radiat Oncol Biol Phys (2005) 1.36
Target volume delineation for partial breast radiotherapy planning: clinical characteristics associated with low interobserver concordance. Int J Radiat Oncol Biol Phys (2007) 1.34
Insulin, macronutrient intake, and physical activity: are potential indicators of insulin resistance associated with mortality from breast cancer? Cancer Epidemiol Biomarkers Prev (2004) 1.31
Preferential dependence of breast cancer cells versus normal cells on integrin-linked kinase for protein kinase B/Akt activation and cell survival. Cancer Res (2006) 1.31
Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases. Breast Cancer Res Treat (2007) 1.30
Age at menarche in the Canadian population: secular trends and relationship to adulthood BMI. J Adolesc Health (2008) 1.29
Changes to osteoporosis prevalence according to method of risk assessment. J Bone Miner Res (2007) 1.28
The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers. Gynecol Oncol (2005) 1.27
The association between body mass index and health-related quality of life: data from CaMos, a stratified population study. Qual Life Res (2007) 1.26
Evolving treatment strategies for inflammatory breast cancer: a population-based survival analysis. J Clin Oncol (2005) 1.24
Development of an ESL curriculum to educate Chinese immigrants about hepatitis B. J Community Health (2008) 1.23
The ratio of positive to excised nodes identifies high-risk subsets and reduces inter-institutional differences in locoregional recurrence risk estimates in breast cancer patients with 1-3 positive nodes: an analysis of prospective data from British Columbia and the M. D. Anderson Cancer Center. Int J Radiat Oncol Biol Phys (2007) 1.21
Controlling angiogenesis in breast cancer: a systematic review of anti-angiogenic trials. Cancer Treat Rev (2012) 1.21
Comparison of breast cancer survival in two populations: Ardabil, Iran and British Columbia, Canada. BMC Cancer (2009) 1.20
Reliability and validity testing of the Patient and Observer Scar Assessment Scale in evaluating linear scars after breast cancer surgery. Plast Reconstr Surg (2007) 1.19
Association between change in BMD and fragility fracture in women and men. J Bone Miner Res (2009) 1.19
Evaluation of a cervical cancer screening intervention for prison inmates. Can J Public Health (2004) 1.19
Temporal trends and determinants of longitudinal change in 25-hydroxyvitamin D and parathyroid hormone levels. J Bone Miner Res (2012) 1.18
Evaluation of a hepatitis B lay health worker intervention for Chinese Americans and Canadians. J Community Health (2009) 1.18
Meta-analysis of genome-wide studies identifies WNT16 and ESR1 SNPs associated with bone mineral density in premenopausal women. J Bone Miner Res (2013) 1.16
Levels of commitment: exploring complementary therapy use by women with breast cancer. J Altern Complement Med (2006) 1.15
Waist-to-hip ratio and breast cancer mortality. Am J Epidemiol (2003) 1.15
Prognosticating futures and the human experience of hope. Palliat Support Care (2007) 1.14
Comparison of cancer incidence in Iran and Iranian immigrants to British Columbia, Canada. Asian Pac J Cancer Prev (2006) 1.13
A population-based study of the fractionation of postlumpectomy breast radiation therapy. In regard to Ashworth et al. Int J Radiat Oncol Biol Phys (2013) 1.13
Does multicentric/multifocal breast cancer differ from unifocal breast cancer? An analysis of survival and contralateral breast cancer incidence. Breast Cancer Res Treat (2008) 1.12
Can clinically relevant prognostic subsets of breast cancer patients with four or more involved axillary lymph nodes be identified through immunohistochemical biomarkers? A tissue microarray feasibility study. Breast Cancer Res (2008) 1.11
Consistency in seroma contouring for partial breast radiotherapy: impact of guidelines. Int J Radiat Oncol Biol Phys (2006) 1.11
Evaluation of methods and costs associated with recruiting healthy women volunteers to a study of ovulation. J Womens Health (Larchmt) (2010) 1.09
Lay beliefs about hepatitis among North American Chinese: implications for hepatitis prevention. J Community Health (2006) 1.09
Dietary patterns in Canadian men and women ages 25 and older: relationship to demographics, body mass index, and bone mineral density. BMC Musculoskelet Disord (2010) 1.08
Insulin-like growth factor receptor (IGF-1R) in breast cancer subtypes. Breast Cancer Res Treat (2011) 1.08
Declining use of mastectomy for invasive breast cancer in Canada, 1981-2000. Can J Public Health (2004) 1.08
Preliminary reliability and validity testing of a new Skin Toxicity Assessment Tool (STAT) in breast cancer patients undergoing radiotherapy. Am J Clin Oncol (2004) 1.07
Risk factors associated with incident clinical vertebral and nonvertebral fractures in postmenopausal women: the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int (2004) 1.06
Dietary patterns and incident low-trauma fractures in postmenopausal women and men aged ≥ 50 y: a population-based cohort study. Am J Clin Nutr (2010) 1.06
Safety, pharmacokinetics, and efficacy of CPX-1 liposome injection in patients with advanced solid tumors. Clin Cancer Res (2009) 1.06
Retracted Kidney function and rate of bone loss at the hip and spine: the Canadian Multicentre Osteoporosis Study. Am J Kidney Dis (2009) 1.05